Neurobiological Pathways and Methodological Rigor in TCM Non-Pharmacological Pain Management

Abstract

With pharmacotherapies frequently constrained by adverse effects and incomplete relief, non-pharmacological modalities derived from Traditional Chinese Medicine, such as acupuncture, manual tuina, moxibustion, and mind-body practices, represent promising non-opioid strategies for chronic pain. This review provides a comprehensive appraisal of their multi-tiered analgesic actions alongside clinical trial methodologies. We delineate modality-specific pathways across peripheral tissue environments, spinal cord gating, and supraspinal circuits, emphasizing the mitigation of neuroinflammation and the reversal of maladaptive central sensitization. Concurrently, our synthesis evaluates the strength of contemporary clinical evidence, revealing how substantial heterogeneity in sham controls, outcome metrics, and practitioner expertise clouds pooled therapeutic estimates. Methodological challenges, most notably the difficulty of inert sham blinding and the disentanglement of physiological actions from placebo expectancy, continue to hinder clinical translation. While emerging multi-omics profiles and functional neuroimaging offer unprecedented insight into biological targets, future validation demands harmonized study protocols and rigorous, mechanism-driven trial designs.